____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 of . CUMBERLAND PHARMACEUTICALS INC A Tennessee Corporation IRS Employer Identification No. 62-1765329 Commission file number 001-33637 1600 West End Avenue, Suite 1300 Nashville, Tennessee 37203 (615) 255-0068 ...